Evaluation of antioxidant deficit in schizophrenia (Q37351067)

19 August 2017

Evaluation of antioxidant deficit in schizophrenia (English)

1 reference

19 August 2017

0 references

Gora Dadheech

1

1 reference

19 August 2017

Sandhya Mishra

series ordinal

2

1 reference

19 August 2017

Shiv Gautam

series ordinal

3

1 reference

19 August 2017

Praveen Sharma

series ordinal

4

1 reference

19 August 2017

1 January 2008

1 reference

Indian Journal of Psychiatry

19 August 2017

1 reference

19 August 2017

50

1 reference

19 August 2017

1

1 reference

19 August 2017

16-20

1 reference

Oxidative stress, α-tocopherol, ascorbic acid and reduced glutathione status in schizophrenics

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

The biochemistry of aging

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Oxidative stress: the paradox of aerobic life

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Reoxygenation injury and antioxidant protection: a tale of two paradoxes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Oxidants and antioxidants: state of the art.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Oxygen radicals and neuropsychiatric illness. Some speculations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

The role of free radicals in toxicity and disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Oxygen radicals and other toxic oxygen metabolites as key mediators of the central nervous system tissue injury

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Oxidative injury and potential use of antioxidants in schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Superoxide dismutase and catalase activities and their correlation with malondialdehyde in schizophrenic patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Free radical pathology and antioxidant defense in schizophrenia: a review

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745854

[The level of lipid peroxidation and the function of the antioxidant system in different forms of schizophrenia]

2 September 2018

1 reference

12 December 2020

The Autoxidation of Human Red Cell Lipids Induced by Hydrogen Peroxide

1 reference

12 December 2020

[Free radicals and neural cell damage]

1 reference

12 December 2020

Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients

1 reference

12 December 2020

[Oxidative stress involvement in schizophrenia pathophysiology: a review]

1 reference

12 December 2020

Identifiers

DOI

10.4103/0019-5545.39753

1 reference

19 August 2017

1 reference

19 August 2017

1 reference